Lantern Pharma Inc. (LTRN) stock
LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.33−0.04 (-9.78%)
Close on Nov 18, 2026Market cap $4.21MP/E –Yield –
Lantern Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lantern Pharma's price to book ratio was 8.6× on Jul 31, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.6× to 13.6×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 8.6× | +5.1 |
| 2025 | Dec 31, 2025 | 3.5× | +2.2 |
| 2024 | Dec 31, 2024 | 1.3× | +0.3 |
| 2023 | Dec 29, 2023 | 1.0× | −0.1 |
| 2022 | Dec 30, 2022 | 1.1× | −0.1 |
| 2021 | Dec 31, 2021 | 1.2× | −4.4 |
| 2020 | Dec 31, 2020 | 5.5× | – |
See a number that looks wrong?